Therapeutic role of psilocybin and 3,4-methylenedioxymethamphetamine in trauma: A literature review

Table 1 Relevant articles to the discussion with the corresponding treatment investigated

Ref.	Publication year	Treatment	Psychiatric diagnosis
Carhart-Harris et al[7]	2021	Psilocybin	Depression
Murphy et al[30]	2021	Psilocybin	Depression
Davis et al[31]	2021	Psilocybin	Depression
Khan et al[34]	2022	Psilocybin	Trauma-related disorders in AIDS patients
Healy et al[35]	2021	Psilocybin	Complex Trauma
Kozlowska et al[36]	2022	Psilocybin	Neurodegenerative disorders
Mitchell et al[16]	2021	MDMA	PTSD
Gorman et al[37]	2020	MDMA	PTSD
Hoskins et al[38]	2021	MDMA	PTSD
Arluk et al[39]	2022	MDMA	PTSD
Monson et al[40]	2020	MDMA	PTSD
Wagner et al[41]	2021	MDMA	PTSD
Bird et al[42]	2021	MDMA	Depression
Nicholas et al[43]	2022	MDMA	Substance use disorders
Ponte et al[44]	2021	MDMA	Sleep disorders
Brewerton et al[45]	2021	MDMA	Eating disorders
Barone et al[46]	2022	MDMA	End-of-life anxiety associated with life-threatening illness

AIDS: Acquired immunodeficiency syndrome; MDMA: 3,4-methylenedioxymethamphetamine; PTSD: Post-traumatic stress disorder.